Table 2 Association of clinical features and number of tertiary lymphoid structures in TME
Features | TNM Stage (n, mean) | P value | Sex (n, mean) | P-value | ||
|---|---|---|---|---|---|---|
I-II | III | Male | Female | |||
Total TLSs | 8.930 | 6.530 | 0.123 | 8.820 | 7.130 | 0.378 |
intratumoral TLSs | 4.110 | 2.110 | 0.053 | 4.270 | 2.370 | 0.555 |
intratumoral eTLSs | 2.260 | 0.740 | 0.036 | 1.770 | 1.500 | 0.770 |
intratumoral pTLSs | 0.700 | 0.470 | 0.094 | 0.950 | 0.290 | 0.453 |
intratumoral sTLSs | 1.150 | 0.890 | 0.528 | 1.550 | 0.580 | 0.570 |
peritumoral TLSs | 4.810 | 4.420 | 0.840 | 4.550 | 4.750 | 0.956 |
peritumoral eTLSs | 3.150 | 2.470 | 0.838 | 2.590 | 3.130 | 0.577 |
peritumoral pTLSs | 0.780 | 0.790 | 0.762 | 0.730 | 0.830 | 0.641 |
peritumoral sTLSs | 0.890 | 1.160 | 0.841 | 1.230 | 0.790 | 0.527 |
